DrugPatentWatch Database Preview

Details for Patent: 7,265,117

« Back to Dashboard

Which drugs does patent 7,265,117 protect, and when does it expire?

Patent 7,265,117 protects QOLIANA and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 7,265,117

Title:	Topical brimonidine tartrate formulations that lack chlorine dioxide
Abstract:	Topical solution compositions of brimonidine tartrate are disclosed. The solution compositions lack an oxidative preservative.
Inventor(s):	Espino; Ramon L. (Cleburne, TX), Bhagat; Haresh G. (Fort Worth, TX)
Assignee:	Alcon, Inc. (Hunenberg, CH)
Application Number:	11/122,651
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 7,265,117
Patent Claim Types: see list of patent claims	Composition; Formulation;

Drugs Protected by US Patent 7,265,117

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sandoz Inc	QOLIANA	brimonidine tartrate	SOLUTION/DROPS;OPHTHALMIC	021764-001	May 22, 2006	AT	RX	No	No			Y

International Family Members for US Patent 7,265,117

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2505836